— Ticker · NMS —
VRTX · Vertex Pharmaceuticals Incorporated
Healthcare · Biotechnology
VRTX
$435.93
▼ -3.21%
7-day move
7-day move
day$433.93 → $441.9952-wk$362.50 → $507.92avg vol1.3M / 3Mcap$110.6B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 20.3 |
| P/E (trailing) | 25.9 |
| EPS (forward) | $21.50 |
| EPS (trailing) | $16.86 |
| PEG | 1.63 |
| Dividend | — |
The Risk
| Beta | 0.30 |
| Short % float | 1.86% |
| Float | 253.0M |
| Shares out | 253.8M |
| Avg vol (3M) | 1.3M |
| 52w range | $362.50 → $507.92 |
The Analyst Tape
strong buybuyholdunderperformsell
$548.10
avg 12-mo target
+25.7%
vs. last · 29 analysts
The Pipeline
$110.6B
market cap
exchangeNMS
sectorHealthcare
industryBiotechnology
market cap$110.6B
websitevrtx.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for VRTX in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for VRTX.
Other Players in the Pipeline
Biotech · by market cap · 7-day move